Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report

Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report Publisher

Amirkhani N¹ ; Khalaji A^{1, 2} ; Alehossein P^{1, 3} ; Safaei M⁴ ; Aletaha N⁵ ; Miroliaee A⁵

Show Affiliations

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
3. Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4. Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
5. Division of Gastroenterology and Hepatology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: JGH Open Published:2023

Abstract

Glatiramer acetate (GA) is a widely used immune-modulating drug in relapsing multiple sclerosis (MS). Although a few cases of drug-induced liver injury during GA therapy have been reported earlier, herein we present the case of a 43-year-old woman with relapsing MS who experienced acute liver failure after GA therapy, ultimately leading to liver transplant. © 2023 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

2. Adverse Side Effects of Glatiramer Acetate and Interferon Beta-1A in Patients With Multiple Sclerosis: A Systematic Review of Case Reports, Current Journal of Neurology (2023)

3. Immunopathogenesis of Multiple Sclerosis: Molecular and Cellular Mechanisms and New Immunotherapeutic Approaches, Immunopharmacology and Immunotoxicology (2024)

Experts (# of related papers)

Mohammad Ali Sahraian (1)

Bagher Larijani (1)

Style	Citing Format
MLA	Amirkhani N, et al.. "Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report." JGH Open, vol. 7, no. 8, 2023, pp. 591-593.
APA	Amirkhani N, Khalaji A, Alehossein P, Safaei M, Aletaha N, Miroliaee A (2023). Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report. JGH Open, 7(8), 591-593.
Chicago	Amirkhani N, Khalaji A, Alehossein P, Safaei M, Aletaha N, Miroliaee A. "Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report." JGH Open 7, no. 8 (2023): 591-593.
Harvard	Amirkhani N et al. (2023) 'Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report', JGH Open, 7(8), pp. 591-593.
Vancouver	Amirkhani N, Khalaji A, Alehossein P, Safaei M, Aletaha N, Miroliaee A. Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report. JGH Open. 2023;7(8):591-593.
BibTex	@article{ author = {Amirkhani N and Khalaji A and Alehossein P and Safaei M and Aletaha N and Miroliaee A}, title = {Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report}, journal = {JGH Open}, volume = {7}, number = {8}, pages = {591-593}, year = {2023} }
RIS	TY - JOUR AU - Amirkhani N AU - Khalaji A AU - Alehossein P AU - Safaei M AU - Aletaha N AU - Miroliaee A TI - Drug-Induced Liver Injury by Glatiramer Acetate Leading to Liver Transplant: A Case Report JO - JGH Open VL - 7 IS - 8 SP - 591 EP - 593 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract